Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

MicroRNA regulation of cancer stem cells.

Liu C, Tang DG.

Cancer Res. 2011 Sep 15;71(18):5950-4. doi: 10.1158/0008-5472.CAN-11-1035. Epub 2011 Sep 13. Review.

PMID:
21917736
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Identification of Differentially Expressed MicroRNAs in Osteosarcoma.

Lulla RR, Costa FF, Bischof JM, Chou PM, de F Bonaldo M, Vanin EF, Soares MB.

Sarcoma. 2011;2011:732690. doi: 10.1155/2011/732690. Epub 2011 Jul 18.

PMID:
21789031
[PubMed]
Free PMC Article
3.

MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.

Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H, Hornicek F.

Mol Cancer Ther. 2011 Aug;10(8):1337-45. doi: 10.1158/1535-7163.MCT-11-0096. Epub 2011 Jun 10.

PMID:
21666078
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.

Maire G, Martin JW, Yoshimoto M, Chilton-MacNeill S, Zielenska M, Squire JA.

Cancer Genet. 2011 Mar;204(3):138-46. doi: 10.1016/j.cancergen.2010.12.012.

PMID:
21504713
[PubMed - indexed for MEDLINE]
5.

MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression.

Osaki M, Takeshita F, Sugimoto Y, Kosaka N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T, Ito H, Oshimura M, Ochiya T.

Mol Ther. 2011 Jun;19(6):1123-30. doi: 10.1038/mt.2011.53. Epub 2011 Mar 22.

PMID:
21427707
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

MicroRNAs as therapeutic targets in cancer.

Nana-Sinkam SP, Croce CM.

Transl Res. 2011 Apr;157(4):216-25. doi: 10.1016/j.trsl.2011.01.013. Epub 2011 Feb 4. Review.

PMID:
21420032
[PubMed - indexed for MEDLINE]
7.

Osteosarcoma: a review of diagnosis, management, and treatment strategies.

Geller DS, Gorlick R.

Clin Adv Hematol Oncol. 2010 Oct;8(10):705-18. Review.

PMID:
21317869
[PubMed - indexed for MEDLINE]
8.

RNA interference in the clinic: challenges and future directions.

Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK.

Nat Rev Cancer. 2011 Jan;11(1):59-67. doi: 10.1038/nrc2966. Epub 2010 Dec 16. Review.

PMID:
21160526
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Targeting the osteosarcoma cancer stem cell.

Siclari VA, Qin L.

J Orthop Surg Res. 2010 Oct 27;5:78. doi: 10.1186/1749-799X-5-78.

PMID:
20979639
[PubMed]
Free PMC Article
10.

Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response.

Gougelet A, Pissaloux D, Besse A, Perez J, Duc A, Dutour A, Blay JY, Alberti L.

Int J Cancer. 2011 Aug 1;129(3):680-90. doi: 10.1002/ijc.25715. Epub 2010 Nov 23.

PMID:
20949564
[PubMed - indexed for MEDLINE]
11.

Targeting microRNAs in cancer: rationale, strategies and challenges.

Garzon R, Marcucci G, Croce CM.

Nat Rev Drug Discov. 2010 Oct;9(10):775-89. doi: 10.1038/nrd3179. Review.

PMID:
20885409
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.

Zhang H, Cai X, Wang Y, Tang H, Tong D, Ji F.

Oncol Rep. 2010 Nov;24(5):1363-9.

PMID:
20878132
[PubMed - indexed for MEDLINE]
13.

miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.

Boni V, Bitarte N, Cristobal I, Zarate R, Rodriguez J, Maiello E, Garcia-Foncillas J, Bandres E.

Mol Cancer Ther. 2010 Aug;9(8):2265-75. doi: 10.1158/1535-7163.MCT-10-0061. Epub 2010 Jul 20.

PMID:
20647341
[PubMed - indexed for MEDLINE]
Free Article
14.

Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

Chen Y, Zhu X, Zhang X, Liu B, Huang L.

Mol Ther. 2010 Sep;18(9):1650-6. doi: 10.1038/mt.2010.136. Epub 2010 Jul 6.

PMID:
20606648
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

MiRNAs as biomarkers and therapeutic targets in cancer.

Heneghan HM, Miller N, Kerin MJ.

Curr Opin Pharmacol. 2010 Oct;10(5):543-50. doi: 10.1016/j.coph.2010.05.010. Epub 2010 Jun 10. Review.

PMID:
20541466
[PubMed - indexed for MEDLINE]
16.

Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.

Susa M, Iyer AK, Ryu K, Choy E, Hornicek FJ, Mankin H, Milane L, Amiji MM, Duan Z.

PLoS One. 2010 May 24;5(5):e10764. doi: 10.1371/journal.pone.0010764.

PMID:
20520719
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.

Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L.

Cancer Res. 2010 Jun 15;70(12):5184-93. doi: 10.1158/0008-5472.CAN-10-0145. Epub 2010 May 25.

PMID:
20501828
[PubMed - indexed for MEDLINE]
Free Article
18.

MicroRNA-21 is involved in osteosarcoma cell invasion and migration.

Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L.

Med Oncol. 2011 Dec;28(4):1469-74. doi: 10.1007/s12032-010-9563-7. Epub 2010 May 18.

PMID:
20480266
[PubMed - indexed for MEDLINE]
19.

Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.

Song B, Wang Y, Titmus MA, Botchkina G, Formentini A, Kornmann M, Ju J.

Mol Cancer. 2010 Apr 30;9:96. doi: 10.1186/1476-4598-9-96.

PMID:
20433742
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Targets for cancer therapy in childhood sarcomas.

Wachtel M, Schäfer BW.

Cancer Treat Rev. 2010 Jun;36(4):318-27. doi: 10.1016/j.ctrv.2010.02.007. Epub 2010 Mar 12. Review.

PMID:
20223596
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk